Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Reem Smoum Jaouni

Reem Smoum Jaouni
The Institute of Drug Research (IDR), School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem Ein Kerem campus, P.O.Box 12065, Jerusalem 91120

Biography

2014 - Present Associate Research Scientist, Institute for Drug Research (IDR), School of Pharmacy, The Hebrew University of Jerusalem 2010 ? 2014 Associate Research Scientist, Bone Laboratory, Faculty of Dental Sciences and Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem 2012 (Jan ? June) Assistant Prof. of Organic Chemistry, Al Quds Bard Honors College, Al Quds University 2007 ? 2010 Postdoctoral Fellow in Medicinal Chemistry, Bone Laboratory, Faculty of Dental Sciences and Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem Sponsors: Raphael Mechoulam and Itai Bab 2001 ? 2004 Teaching and Research Assistant, Department of Medicinal Chemistry and Natural Products, School of Pharmacy, The Hebrew University of Jerusalem 1996 ? 1997 Teaching and Research Assistant, Department of Chemistry, Birzeit University, Ramallah

Research Interest

Chemistry and biological effects of natural products and drugs. Specifically, the design and synthesis of novel cannabinoids and endocannabinoids-like compounds to be tested against pain, inflammation, high blood pressure, cancer and osteoporosis.